Traitement des paraostéoarthropathies neurogènes par le Pamidronate®

Banovac, 1993, Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossifications, Paraplegia, 31, 660, 10.1038/sc.1993.106 Bidner, 1990, Evidence for a humoral mechanism for enhanced osteogenesis after head injury, J Bone Jt Surg, 72A, 1144, 10.2106/00004623-199072080-00004 Ekelund, 1991, Experimental induction of heterotopic bone, Clin Orthop Rel Res, 263, 102, 10.1097/00003086-199102000-00011 Fleish, 1993, Biphosphonates in bone diseases. From the laboratory to the patient, 144 Gallacher, 1991, Clinical experience with pamidronate in the treat- ment of Paget's disease of bone, Ann Rheum Dis, 50, 930, 10.1136/ard.50.12.930 Garland, 1983, Diphosphonate treatment of heterotopic ossification in spinal cord injury patient, Clin Orthop Rel Res, 176, 197, 10.1097/00003086-198306000-00028 Kurer, 1992, Human osteoblast stimulation by sera from paraplegic patients with heterotopic ossification, Paraplegia, 30, 165, 10.1038/sc.1992.48 Hu, 1991, The effect of biphosphonates on induced heterotopic bone, Clin Orthop Rel Res, 272, 259, 10.1097/00003086-199111000-00039 Leroux, 1987, L'ethane hydroxy diphosphonate dans le traitement des paraostéoarthropathies nerveuses, 47 Mysiv, 1993, Heterotopic ossification: the utility of osteocalcin in diagnosis and management, Am J Phys Med Rehabil, 72, 184, 10.1097/00002060-199308000-00002 Pélissier, 1983, Traitement précoce par l'éthane hydroxydiphosphonate des paraostéoarthropathies neurogènes des traumatisés craniens, 109 Pélissier, 1995, Traitements médicamenteux des paraostéoarthropathies neurogènes, 1 vol, 41 Spielman, 1983, Disodium etidronate: its role in preventing heterotopic ossification in severe head injury, Arch Phys Med Rehabil, 64, 539 Stover, 1975, Heterotopic ossifications in spinal cord injured patients, Arch Phys Med Rehabil, 56, 199 Van der Linden, 1984, Spontaneous regression of neurogenic heterotopic ossification, Int Orthop, 8, 25, 10.1007/BF00267736